Hemab Therapeutics Holdings, Inc.

COAG Nasdaq Healthcare · Biological Products, (No Diagnostic Substances) Cambridge, MA www.hemab.com/
$39.05
Mkt Cap 1.82B

Biotech developing preventative treatments for patients with rare bleeding and thrombotic disorders.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…